Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 32.13M | $136.0M | 10.37% | +3.53M | 2026-06-30 |
| Rubric Capital Management LP | 18.00M | $76.0M | 5.81% | +14.38M | 2026-06-30 |
| STATE STREET CORP | 16.17M | $68.0M | 5.22% | -2.51M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 13.17M | $56.0M | 4.25% | +278.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 7.95M | $33.0M | 2.56% | +442.1K | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 7.84M | $33.0M | 2.53% | +4.56M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 6.60M | $28.0M | 2.13% | +700.0K | 2026-06-30 |
| Deep Track Capital, LP | 6.00M | $25.0M | 1.94% | -- | 2026-06-30 |
| 180 WEALTH ADVISORS, LLC | 4.96M | $21.0M | 1.60% | +668.1K | 2026-06-30 |
| FMR LLC | 4.10M | $17.0M | 1.32% | +620.1K | 2026-06-30 |
